My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Illumina, Inc. - Common Stock (NQ:ILMN)

143.96 +2.63 (+1.86%)

Streaming Delayed Price Updated: 1:21 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

The Caracas Coup: Markets Surge as 'Weekend Capture' Reshapes Global Energy and Geopolitics

Today 10:24 EST

The first full trading week of 2026 has opened with a seismic shift in both the geopolitical landscape and the financial markets. Following the dramatic "weekend capture" of Venezuelan President...

Via MarketMinute

1 Profitable Stock to Own for Decades and 2 Facing Challenges

January 04, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

ILLUMINA INC (NASDAQ:ILMN) Shows Bull Flag Setup Ahead of Potential Breakout ↗

December 30, 2025

ILLUMINA INC (ILMN) shows a strong technical breakout setup with a high trend rating and a defined bull flag pattern, suggesting a potential entry point for momentum traders.

Via Chartmill

Is Illumina Inc Gaining or Losing Market Support? ↗

December 22, 2025

Via Benzinga

Wix Stock Tumbles 50% in One Year — But Is Vibe-Coding AI Platform Base44 the Reason This Fund Is Doubling Down? ↗

December 09, 2025

A major hedge fund just made a beaten-down tech name its largest bet.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Why One Fund Dumped $74 Million of Bank OZK Stock Despite a Record $180.5 Million Earnings ↗

December 09, 2025

Why would a fund walk away from a bank that just posted record earnings?

Via The Motley Fool

This Fintech Stock Is Down 70% — But a Hedge Fund Just Boosted Its $66 Million Stake ↗

December 09, 2025

A major hedge fund just made a bold bet on a fintech name that’s quietly turning its fundamentals around — here’s what they’re likely seeing.

Via The Motley Fool

EPAM Stock Is Down 15% This Past Year — But This Fund Is Betting $146 Million on a Turnaround ↗

December 09, 2025

EPAM’s latest results suggest its long slump may be out of sync with its fundamentals — here’s why a major hedge fund just doubled down.

Via The Motley Fool

popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery

November 25, 2025

Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the...

Via TokenRing AI

Topics Artificial Intelligence

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Illumina Inc (NASDAQ:ILMN) Presents a Compelling Case for Value Investors ↗

November 19, 2025

Illumina (ILMN) offers strong value with low valuation metrics, high profitability, and solid financial health, making it an intriguing stock for value investors.

Via Chartmill

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

November 18, 2025

Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 per share. This was partly due to its solid quarterly results, and the...

Via StockStory

3 Unpopular Stocks with Warning Signs

November 16, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

1 Momentum Stock with Promising Prospects and 2 We Avoid

November 13, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes

November 11, 2025

Nvidia's (NASDAQ: NVDA) recent stock performance has been a whirlwind of soaring highs and sharp corrections, acting as a potent barometer for the broader Wall Street landscape as of November 11, 2025....

Via MarketMinute

Topics Artificial Intelligence Economy Law Enforcement

Cisco, Morgan Stanley, FTAI Aviation And A Health Care Stock On CNBC's 'Final Trades' ↗

November 11, 2025

On CNBC's "Halftime Report," Cerity Partners' Jim Lebenthal named Cisco Systems as his final trade and that the fundamentals justify it.

Via Benzinga

AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps

November 10, 2025

The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable...

Via TokenRing AI

Topics Artificial Intelligence

1 Profitable Stock Worth Investigating and 2 Facing Headwinds

November 06, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

5 Revealing Analyst Questions From Illumina’s Q3 Earnings Call

November 06, 2025

Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit expectations, with positive market reaction following the report. Management...

Via StockStory

Topics Earnings

10x Genomics Earnings: What To Look For From TXG

November 04, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

PacBio Earnings: What To Look For From PACB

November 03, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Illumina (ILMN) Stock Trades Down, Here Is Why

November 03, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The...

Via StockStory

Topics Artificial Intelligence Supply Chain

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗

November 03, 2025

Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025.

Via Benzinga

Topics ETFs

Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗

November 02, 2025

Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results.

Via Benzinga

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗

October 31, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 31, 2025

Via Benzinga

Why Illumina (ILMN) Stock Is Up Today

October 31, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year...

Via StockStory

Topics Economy Government World Trade

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗

October 31, 2025

Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets.

Via Benzinga

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗

October 31, 2025

Via Benzinga

ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance

October 31, 2025

Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.